Hyaluronic acid injections in medicare knee osteoarthritis patients are associated with longer time to knee arthroplasty

この研究はインパクトが大きい可能性があると判断されました。 OEのAIによるハイインパクト指標は、論文が掲載されたジャーナルと論文自体の科学的内容の両方からのシグナルを統合することで、論文の影響力を推定します。 最先端の自然言語処理を用いて開発されたOEハイインパクトモデルは、ジャーナルのインパクトファクターのみよりも、研究の将来の引用実績をより正確に予測します。 これにより、臨床的に意義のある研究をより早く認識することができ、読者は将来の診療を形成する可能性が最も高い論文に焦点を当てることができます。

研究概要

A 5% sample of Part B Medicare data from 2005-2012 was used in this retrospective , observational study examining the use of intra-articular hyaluronic acid (IA-HA) injections in patients with knee osteoarthritis (OA). Patients were identified based on the presence of specific codes as having knee OA or non-specific OA + knee pain. Patients were further identified as having used IA-HA treatment in the knee joint or having received a knee arthroplasty (KA) with or without at least 1 IA-HA. Additional comparisons were made between time from knee OA to KA and between those who received Euflexxa IA-HA and those who did not. Patient comorbid conditions were also evaluated.